Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma

BACKGROUND: Immunotherapy is one of the research hotspots in the field of hepatocellular carcinoma (HCC). Successive clinical trials have shown that patients with CTNNB1 mutations are resistant to immunotherapy, but the mechanism is still unclear. MATERIAL/METHODS: We identified differentially expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Junyu, Wu, Liqun, Zang, Yunjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Database Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523420/
https://www.ncbi.nlm.nih.gov/pubmed/32945289
http://dx.doi.org/10.12659/MSM.925494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523420/
https://www.ncbi.nlm.nih.gov/pubmed/32945289
http://dx.doi.org/10.12659/MSM.925494

Ejemplares similares